Orion Oyj
ORINF
Updated: 23/09/2026, 08:28:41
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
No summaries found.
- Share price
- $92.05
- Market cap
- $12.97B
- Exchange
- OTC
- Currency
- USD
- CEO
- Aino Anna Liisa Hurme
- Employees
- 4,029
- IPO date
- 28/05/2013
- Beta
- 0.329
- Last dividend
- $0.00
- Day range
- $92.05 – $92.05
- 52-week range
- $78.95 – $92.05
- 1-day performance
- 0.00%
- 1-year performance
- 16.59%
- Current drawdown (1Y)
- 0.00%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- FI0009014377
- Created
- 07/12/2025, 05:37:36
- Last update
- 23/09/2026, 08:28:41
Track Orion Oyj with an AI analyst
See which prediction-market events move ORINF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.